ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,696, issued on Oct. 28, was assigned to Eligo Bioscience (Paris).
"Cutibacterium acnes recombinant phages encoding a human protein" was invented by Aymeric Leveau (Paris), Ines Canadas Blasco (Paris), Aurelie Mathieu (Paris) and Antoine Decrulle (Paris).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to C. acnes strains carrying DNA vectors for the production of recombinant C. acnes phages. The invention encompasses a C. acnes producer cell carrying DNA vectors, with a template for recombination with C. acnes phage genome leading to the insertion of a gene of interest, for the production of recombinant phages that can lead to the...